The Long-term Outcomes of Cirrhotic Patients with Pleural Effusion

doi:10.4103/sjg.SJG_336_17

機構典藏 > College of Sciences > Department of Applied Mathematics and Data Science > Journal Article > Item 987654321/112715

Please use this identifier to cite or link to this item: https://tkuir.lib.tku.edu.tw/dspace/handle/987654321/112715

Title:	The Long-term Outcomes of Cirrhotic Patients with Pleural Effusion
Authors:	Hung, T. H.;Tseng, C. W.;Tsai, C. C.;Tsai, C. C.;Tseng, K. C.;Hsieh, Y. H.
Keywords:	End-stage liver disease;hepatic hydrothorax;hepatic insufficiency
Date:	2018-01
Issue Date:	2018-03-02 12:10:45 (UTC+8)
Abstract:	BACKGROUND/AIM: A pleural effusion is an abnormal collection of fluid in the pleural space and may cause related morbidity or mortality in cirrhotic patients. Currently, there are insufficient data to support the long-term prognosis for cirrhotic patients with pleural effusion. In this study, we investigated the short- and long-term effects of pleural effusion on mortality in cirrhotic patients and evaluated the benefit of liver transplantation in these patients. PATIENTS AND METHODS: The National Health Insurance Database, derived from the Taiwan National Health Insurance Program, was used to identify 3,487 cirrhotic patients with pleural effusion requiring drainage between January 1, 2007 and December 31, 2010. The proportional hazards Cox regression model was used to control for possible confounding factors. RESULTS: The 30-day, 90-day, 1-year, and 3-year mortalities were 20.1%, 40.2%, 59.1%, and 75.9%, respectively, in the cirrhotic patients with pleural effusion. After Cox proportional hazard regression analysis adjusted by patient gender, age, complications of cirrhosis and comorbid disorders, old age, esophageal variceal bleeding, hepatocellular carcinoma, hepatic encephalopathy, pneumonia, renal function impairment, and without liver transplantation conferred higher risks for 3-year mortality in the cirrhotic patients with pleura effusion. Liver transplantation is the most important factor to determine the 3-year mortalities (HR: 0.17, 95% CI 0.11- 0.26, P < 0.001). The 30-day, 30 to 90-day, 90-day to 1-year, and 1 to 3-year mortalities were 5.7%, 13.4%, 20.4%, and 21.7% respectively, in the liver transplantation group, and 20.5%, 41.0%, 61.2%, and 77.5%, respectively, in the non-liver transplantation group. CONCLUSION: In cirrhotic patients, the presence of pleural effusion predicts poor long-term outcomes. Liver transplantation could dramatically improve the survival and should be suggested as soon as possible.
Relation:	Saudi J Gastroenterol 24(1), p.46-51
DOI:	10.4103/sjg.SJG_336_17
Appears in Collections:	[Department of Applied Mathematics and Data Science] Journal Article

Files in This Item:

File	Description	Size	Format
index.html		0Kb	HTML	239	View/Open
The Long-term Outcomes of Cirrhotic Patients with Pleural Effusion.pdf		637Kb	Adobe PDF	0	View/Open

Loading...